Formulation and evaluation of a mucoadhesive buccal drug delivery system of Atomoxetine hydrochloride for improved bioavailability

Authors

  • Ashutosh Dinkar Nerkar Department of Pharmaceutics, Bhabha Pharmacy Research Institute, India
  • Ayush Pratap Singh Sengar Department of Pharmaceutics, Bhabha Pharmacy Research Institute, India
  • Raghuraj Lovanshi Department of Pharmaceutics, Bhabha Pharmacy Research Institute, India
  • OP Agrawal Department of Pharmaceutics, Bhabha Pharmacy Research Institute, India

Keywords:

Atomoxetine Hydrochloride, Buccal Film, Mucoadhesion, Controlled Release, Ion-Exchange Resin, Bioavailability

Abstract

Atomoxetine Hydrochloride (ATX HCl), a selective norepinephrine reuptake inhibitor (SNRI), suffers from low oral bioavailability due to extensive hepatic first-pass metabolism and bitter taste, limiting compliance in pediatric ADHD patients. The present study aimed to formulate and evaluate a mucoadhesive buccal drug delivery system of ATX HCl to overcome these limitations. Preformulation studies established physicochemical compatibility between the drug and selected polymers (HPMC K15M, Carbopol 934P, PVP K30). A drug–resin complex (DRC) utilizing Tulsion 339 (1:2 ratio) was prepared for taste masking. Buccal films were fabricated using the solvent casting method and optimized through systematic variation of polymer and plasticizer ratios. The optimized formulation (F3) exhibited excellent mechanical properties, neutral surface pH, satisfactory mucoadhesive strength (17.8 g), and sustained drug release (91% in 6 h), following Higuchi kinetics (R² = 0.994) with non-Fickian diffusion (n = 0.62). Ex vivo permeation across porcine buccal mucosa confirmed 82% permeation within 6 h. Analytical methods (UV at 272 nm and HPLC at t_r = 3.9 minutes) were validated as per ICH Q2(R2). Accelerated stability studies revealed no significant changes in drug content, appearance, or release profile over 6 months. The findings demonstrate that the developed mucoadhesive buccal film offers a promising alternative to conventional oral therapy by enhancing bioavailability, controlling release, masking bitterness, and improving patient compliance.

Downloads

Download data is not yet available.

References

Jain, S., & Kaur, R. Buccal delivery systems for CNS drugs. Journal of Controlled Release, 2023; 355, 114–122.

Kamboj, S., Saini, V., & Bala, R. Mucoadhesive drug delivery systems: A review. Asian Journal of Pharmaceutical and Clinical Research, 2017; 10(4), 24–29.

Khutoryanskiy, V. V. Mucoadhesive materials and drug delivery systems. Journal of Advanced Drug Delivery Reviews, 2014; 57(11), 2301–2320.

Kumar, M., & Sharma, P. Ion exchange resins for taste masking: A review. International Journal of Applied Pharmaceutics,2015; 7(2), 1–6.

Kumar, S., et al. Formulation and evaluation of buccal films: A review. International Journal of Pharmaceutical Investigation, 2021; 11(2), 150–160.

Patel, R., Sharma, P., & Desai, N. Development of mucoadhesive buccal films for systemic delivery. International Journal of Pharmaceutics,2021; 598, 120310.

Jain, S., & Kaur, R. Buccal drug delivery systems for CNS-active agents. Journal of Controlled Release, 2023; 355, 114–122.

United States Pharmacopeia (USP 2022). Drug Release and Mucoadhesion Testing Methods.

ICH Q2(R2). Validation of Analytical Procedures: Text and Methodology.

ICH Q1A(R2). Stability Testing of New Drug Substances and Products.

Content extracted and adapted from thesis document: Atomoxetine Hydrochloride Buccal Drug Delivery System.

Lodhi, G., Prabhu, P., & Shah, S. Buccal adhesion and permeation enhancement: A review. Pharmaceutical Nanotechnology, 2019; 7(1), 23–33.

Mozaffari, N., et al. Solvent casting method in film formulation. Journal of Polymers, 2018; 12(3), 45–55.

Patel, R. B., & Bharadia, P. D. Buccal films for systemic delivery. International Journal of Pharmaceutics, 2021; 598, 120310.

Remuńán-López, C., et al. Chitosan–carbopol interpolymer complexes and mucoadhesive strength. European Journal of Pharmaceutics and Biopharmaceutics, 2014; 67(3), 401–409.

Shah, V. P., & Yacobi, A. Biopharmaceutics of buccal absorption. Biopharmaceutics & Drug Disposition, 2020; 41(4), 175–189.

Shojaei, A. H. Buccal mucosa as a route for systemic drug delivery. Journal of Pharmacy & Pharmaceutical Sciences, 2012; 1(1), 15–30.

Sultana, K., et al. Design and evaluation of buccal films. Saudi Pharmaceutical Journal, 2018; 26(3), 418–425.

Thakur, N., et al. Formulation strategies for taste masking of bitter drugs. Journal of Drug Delivery Science and Technology, 2020; 60, 102041.

Allen, L. V., & Ansel, H. C. Pharmaceutical Dosage Forms and Drug Delivery Systems (12th ed.). Wolters Kluwer.

Aulton, M. E., & Taylor, K. (2018). Aulton’s Pharmaceutics: The Design and Manufacture of Medicines (5th ed.). Elsevier.

Bonferoni, M. C., Rossi, S., Sandri, G., & Caramella, C. Mucoadhesive drug delivery systems. Expert Opinion on Drug Delivery, 2015; 12(3), 365–378.

Chinna Reddy, P., & Chaitanya, K. Buccal drug delivery: An innovative route. Journal of Drug Delivery Science and Technology, 2017; 37, 125–133

Downloads

Published

2025-11-30

Issue

Section

Research Articles

How to Cite

1.
Formulation and evaluation of a mucoadhesive buccal drug delivery system of Atomoxetine hydrochloride for improved bioavailability. Int J Adv Pharm [Internet]. 2025 Nov. 30 [cited 2026 Jan. 3];14(1):e5882. Available from: https://ssjournals.co.in/index.php/ijap/article/view/5882